Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
11°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Gemina Laboratories Ltd.
Gemina Labs Announces Closing Of Concurrent Private Placement
July 11, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Tickers
CSE:GLAB
Gemina Announces Closing Of Prospectus Supplement Offering And Update To Concurrent Non-brokered Private Placement
June 30, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Tickers
CSE:GLAB
Gemina Announces Filing of Prospectus Supplement
June 24, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Tickers
CSE:GLAB
Gemina Announces Proposed Financing Up to $5 Million
June 21, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Tickers
CSE:GLAB
Gemina Labs Appoints Point-of-Care Diagnostic Executive Brian Firth as Advisor
June 08, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Tickers
CSE:GLAB
Gemina Labs Announces CE Mark for its First Product - The Best in Class Legio-X COVID Rapid Antigen Test
May 17, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Gemina Labs Completes Successful Human Clinical Performance Evaluation on its Legio X COVID-19 Rapid Antigen Test
May 05, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Gemina Labs Nears Completion of Phase 2 Human Patient Testing for Initial Diagnostic Test
April 28, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Gemina Labs Provides Technical Development Update for Initial Diagnostic Test and Reports Filing of New IP
March 31, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Gemina Labs Establishes UK Subsidiary And Appoints David Browning As Head Of Productization
February 23, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Tickers
CSE:GLAB
Gemina Labs Strategic Update: From Product to Platform, Gemina Provides a Technology Roadmap
February 15, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Tickers
CSE:GLAB
Gemina Labs Announces Completion of Significant Development Step for its SARS-CoV-2 Rapid Test
February 03, 2022
From
Gemina Laboratories Ltd.
Via
AccessWire
Tickers
CSE:GLAB
Gemina Labs Announces Appointment Of Senior Scientific Adviser
November 18, 2021
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Gemina Labs Announces Closing of Oversubscribed Private Placement
October 25, 2021
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Gemina Labs Announces Private Placement
October 20, 2021
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Gemina Labs Receives Positive Initial Manufacturing Results for SARS-CoV-2 Diagnostic Test
September 20, 2021
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Gemina Labs Provides Research and Development and Corporate Update
September 13, 2021
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Gemina Labs Announces Research and Development Appointments
August 30, 2021
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Gemina Labs Announces Listing on the Canadian Securities Exchange
August 10, 2021
From
Gemina Laboratories Ltd.
Via
AccessWire
Exposures
COVID-19
Tickers
CSE:GLAB
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.